Silintan joint pain supplements were recalled nationwide after FDA testing found undeclared meloxicam | Image via FDA/company press release.
Federal regulators say a joint pain supplement sold nationwide has been pulled from the market after testing found a hidden prescription-strength drug that can trigger serious and potentially life-threatening health effects.
The U.S. Food and Drug Administration posted a company announcement stating that Anthony Trinh, of 123Herbals LLC has issued a voluntary nationwide recall of all lots of Silintan capsules after agency analysis found the product contained undeclared meloxicam, a prescription-only nonsteroidal anti-inflammatory drug (NSAID) that cannot legally be sold as a dietary supplement.
According to the FDA notice, the company announced the recall on January 7, 2026, and the agency published the notice on January 9, 2026.
Silintan capsules were marketed as a dietary supplement for relief of joint and body aches and were sold nationwide through the website 123herbals.com, according to the FDA. The affected products were packaged in 25-count plastic bottles with blue labels, and the recall applies to all lot numbers within expiry.
The recalled product was sold in packaging featuring foreign-language text and marketed online to U.S. consumers, according to the FDA.
The FDA said products containing meloxicam are considered unapproved new drugs when sold as supplements because their safety and effectiveness have not been established under the standards required for prescription medications.
The agency warned that exposure to meloxicam — particularly at doses exceeding the recommended maximum daily dose of 15 milligrams — may carry a reasonable probability of serious adverse events, including blood clots, heart attack, and stroke.
Additional risks cited by the FDA include gastrointestinal bleeding, ulceration, kidney injury, hypersensitivity reactions, and dangerous drug interactions, especially for individuals taking blood thinners or other NSAIDs.
Company officials said they have not received any reports of adverse events linked to the recalled product. According to the FDA notice, 123Herbals is notifying distributors and customers by email and arranging returns. Consumers were advised to stop using the product and either return it, discard it, or consult a physician.
The recall comes amid a growing series of FDA actions involving dietary supplements alleged to contain hidden pharmaceutical ingredients.
Earlier this month, a metabolic and cognitive supplement sold under the Modern Warrior Ready brand was recalled after regulators reported finding undeclared substances including tianeptine, 1,4-DMAA, and aniracetam — compounds the FDA said pose serious cardiovascular and mental health risks, particularly for younger users, according to previous The Dallas Express reporting.
In December, the FDA announced another recall involving MR.7 SUPER 700000 supplements after agency testing identified hidden sildenafil and tadalafil — the active ingredients in Viagra and Cialis — which can cause dangerous drops in blood pressure when combined with certain medications, according to a prior DX report.
